Roth RNA Revolution Conference

Investors

Roth RNA Revolution Conference

Jul 17, 2019

Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.